Lv7
4880 积分 2025-07-01 加入
Cell and Gene Therapy Product Approvals in China: Insights into Clinical Trials and Regulatory Advances
8小时前
待确认
Trends in the development of cellular and gene therapy in China
9小时前
已完结
Phase 1/2 Trial of Anti-CD7 Allogeneic WU-CART-007 in patients with Relapsed/Refractory T-cell Malignancies
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells
3个月前
已完结
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
3个月前
已完结
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
3个月前
已完结
Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation
4个月前
已完结
皖公网安备34019202002308
